Your browser doesn't support javascript.
loading
Changes in the expression of mexB, mexY, and oprD in clinical Pseudomonas aeruginosa isolates.
Matsumoto, Yoshimi; Yamasaki, Seiji; Hayama, Kouhei; Iino, Ryota; Noji, Hiroyuki; Yamaguchi, Akihito; Nishino, Kunihiko.
  • Matsumoto Y; SANKEN (The Institute of Scientific and Industrial Research), Osaka University.
  • Yamasaki S; SANKEN (The Institute of Scientific and Industrial Research), Osaka University.
  • Hayama K; Graduate School of Pharmaceutical Sciences, Osaka University.
  • Iino R; Institute for Advanced Co-Creation Studies, Osaka University.
  • Noji H; SANKEN (The Institute of Scientific and Industrial Research), Osaka University.
  • Yamaguchi A; Institute for Molecular Science, National Institutes of Natural Sciences.
  • Nishino K; Graduate Institute for Advanced Studies, The Graduate University for Advanced Studies (SOKENDAI).
Article en En | MEDLINE | ID: mdl-38199247
ABSTRACT
Changes in expression levels of drug efflux pump genes, mexB and mexY, and porin gene oprD in Pseudomonas aeruginosa were investigated in this study. Fifty-five multidrug-resistant P. aeruginosa (MDRP) strains were compared with 26 drug-sensitive strains and 21 strains resistant to a single antibiotic. The effect of the efflux inhibitor Phe-Arg-ß-naphthylamide on drug susceptibility was determined, and gene expression was quantified using real-time quantitative real-time reverse transcription polymerase chain reaction. In addition, the levels of metallo-ß-lactamase (MBL) and 6'-N-aminoglycoside acetyltransferase [AAC(6')-Iae] were investigated. Efflux pump inhibitor treatment increased the sensitivity to ciprofloxacin, aztreonam, and imipenem in 71%, 73%, and 29% of MDRPs, respectively. MBL and AAC(6')-Iae were detected in 38 (69%) and 34 (62%) MDRP strains, respectively. Meanwhile, 76% of MDRP strains exhibited more than 8-fold higher mexY expression than the reference strain PAO1. Furthermore, 69% of MDRP strains expressed oprD at levels less than 0.01-fold of those in PAO1. These findings indicated that efflux pump inhibitors in combination with ciprofloxacin or aztreonam might aid in treating MDRP infections.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pseudomonas aeruginosa / Aztreonam Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pseudomonas aeruginosa / Aztreonam Idioma: En Año: 2024 Tipo del documento: Article